60 studies found for:    Open Studies | "Diabetic Nephropathies"
Show Display Options
Rank Status Study
1 Recruiting Glutathione in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Proteinuria;   Oxidative Stress
Interventions: Drug: N-acetylcysteine placebo + silibin placebo;   Drug: N-acetylcysteine active + silibin placebo;   Drug: N-acetylcysteine placebo + silibin active;   Drug: N-acetylcysteine active + silibin active;   Drug: N-acetylcysteine active + high-dose silibin active
2 Recruiting Renal Denervation in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Persistent Proteinuria With Type II Diabetes
Interventions: Procedure: Percutaneous renal denervation and TMNS;   Drug: Standardized antiproteinuric medication regimen includes an angiotensin receptor blocker , a diuretic , 25OH vitamin D3 and a statin
3 Unknown  Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Conditions: Diabetic Nephropathy;   Chronic Kidney Disease
Intervention: Drug: Mycophenolate Mofetil (MMF) ,phosphodiesterase 5 inhibitors , CARNITINE
4 Unknown  N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Conditions: Diabetic Nephropathies;   Proteinuria;   Oxidative Stress
Interventions: Dietary Supplement: N-acetylcysteine;   Dietary Supplement: silibin;   Dietary Supplement: high-dose silibin;   Dietary Supplement: N-acetylcysteine placebo;   Dietary Supplement: silibin placebo
5 Not yet recruiting The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention:
6 Recruiting Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: MT-3995;   Drug: Placebo
7 Unknown  Association Between Rosiglitazone Use and Clinical Course of Diabetic Nephropathy: Population-Based Study
Conditions: Diabetes;   Diabetic Nephropathy;   Renal Protection
Intervention: Drug: Rosiglitasone (retrospective observation)
8 Recruiting Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 2;   Diabetic Nephropathy
Interventions: Drug: Canagliflozin;   Drug: Placebo
9 Recruiting Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Conditions: Diabetic Nephropathy;   Diabetic Retinopathy
Interventions: Drug: Spironolactone;   Drug: Placebo;   Drug: Standard care
10 Recruiting Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
Conditions: Diabetes Type 2;   Diabetic Nephropathy;   Vascular Disease
Interventions: Drug: Ramipril;   Drug: Clopidogrel
11 Recruiting Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
12 Recruiting Validation of Biomarkers of Diabetic Nephropathy in Type I Diabetic Children
Condition: Type 1 Diabetes Mellitus With Diabetic Nephropathy
Intervention: Other: Urinary sample collection
13 Recruiting Colchicine for Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: colchicine
14 Unknown  Aldosterone in Diabetic Nephropathy
Condition: Diabetic Nephropathy
Interventions: Drug: Spironolactone;   Drug: Placebo
15 Recruiting Study Of Diabetic Nephropathy With Atrasentan
Condition: Diabetic Nephropathy
Interventions: Drug: Atrasentan;   Drug: Placebo
16 Recruiting Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy
Condition: Diabetic Nephropathy
Intervention: Drug: Beraprost sodium
17 Recruiting Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
Conditions: Kidney Diseases;   Kidney Failure, Chronic;   Diabetic Nephropathy;   Lupus Nephritis;   Glomerulonephritis, IGA
Intervention:
18 Unknown  Study for the Effectiveness of Intensive Therapy Aiming at a Remission of Diabetic Nephropathy
Conditions: Type 2 Diabetes Mellitus;   Diabetic Nephropathy
Interventions: Drug: ACE inhibitors,ARB, HMG-CoA reductase inhibitors, vitamins;   Behavioral: Compliance, antismoking, and nutrition instruction
19 Recruiting Effect of Topiroxostat on Urinary Albumin Excretion Early Stage Diabetic Nephropathy and Hyperuricemia With or Without Gout
Condition: Diabetic Nephropathy
Interventions: Drug: Topiroxostat BID, (Oral daily dosing for 28 weeks);   Drug: Placebo BID, (Oral daily dosing for 28 weeks)
20 Recruiting Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease
Condition: Diabetic Nephropathies
Interventions: Drug: Moxonidine;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years